Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
Preemie Babies End Up Hospitalized More as KidsCommon Weight-Loss Surgery Can Weaken a Teen's BonesAnother Study Finds COVID Usually Mild in KidsParents' Age Key to Whether Kids Get Vaccinated Against COVID, Study FindsDoes Parents' Nagging Kids About Screen Time Even Matter?Which Kids With COVID Will Get Very Sick?Add Kids to COVID Vaccine Trials, Pediatricians' Group SaysToo Many Kids Still Get Antipsychotics They Don't NeedIs the Pandemic Harming Kids' Mental Health?Eczema More Common Among Black, Hispanic KidsTelemedicine Is Keeping Kids' Asthma Care on Track: StudyKids With Food Allergies Can Become Targets for BulliesHelp Young Athletes Keep Their Competitive Edge During PandemicAlmost 1 in 5 Parents Are 'Vaccine Hesitant,' Study FindsFor Rural Youth, Mental Health Care Can Be Tough to FindAre Healthy Kids Getting Too Many Heart Tests?Big Spike Seen in COVID Cases Among KidsAsymptomatic Kids With COVID-19 May Also Carry Less VirusLockdowns Can Widen Kids' Waistlines – Here's How to Curb ThatSocial Media 'Kid Influencers' Are Promoting Junk FoodsPoverty Might Raise Black Kids' Health Risks as Early as Age 5It's Tough to Change the Minds of 'Vaccine-Hesitant' Parents, Study FindsStudy Probes Links in Asthma, Food Sensitivity and Irritable Bowel SyndromeYour Guide to a Safe and Happy HalloweenKids' Hospitalizations Accompany Rising Unemployment Rates: StudyMusic Classes Strike a Chord in Kids' Brain Development: StudyPediatricians' Group Tackles Racism in Health CarePandemic Silver Lining: Steep Drop in Kids' FracturesPlan Ahead to Keep Halloween Safe for Kids With Asthma, AllergiesEarly School Sports Reduce ADHD Symptoms Years Later for GirlsDo Minority Kids Face More Danger During Surgeries?1 in 3 U.S. Parents Won't Get Flu Shots for Their Kids: SurveyKids Much Less Prone to Coronavirus Infection Than Adults: StudyImmune System Clues to Why COVID Is Easier on KidsFDA Warns of Danger From 'Benadryl Challenge,' Asks TikTok to Remove VideosAfter COVID-19 Exposure, When Can Young Athletes Resume Play?Kids Who Need Steroids Face Risk of Diabetes, Other IllsMom-to-Be's Pot Use Linked With Higher Odds for Kids' Mental WoesKids Often Hit Hard by Death of Beloved Pet, Study FindsHolidays Can Be a Fright for Kids With Food AllergiesHow to Help Ensure Your Students Get Enough SleepAs Schools Reopen, Many Students, Staff Live With High-Risk Family MemberBlack Kids at Higher Odds for ADHDProbiotic Might Help Ease Children's EczemaMore Than 1 in 3 U.S. Pediatricians Dismiss Vaccine-Refusing FamiliesDeath From COVID-19 Very Rare for Americans 21 and Under: ReportAre School Lunches a Ticket to Healthy Eating?Are At-Home 'Learning Pods' the Right Fit for Your Family?Kids at 2 Utah Day Cares Easily Spread COVID to FamiliesChildren Use Both Sides of the Brain to Understand Language
Links
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Parenting
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Probiotic Might Help Ease Children's Eczema

HealthDay News
by By Amy Norton
HealthDay Reporter
Updated: Sep 15th 2020

new article illustration

TUESDAY, Sept. 15, 2020 (HealthDay News) -- Applying a type of "good" bacteria to the skin may relieve children of the itch and discomfort of eczema, a new, small study suggests.

Eczema is a chronic inflammatory condition that causes dry, itchy skin and scaly rashes. It usually starts in early childhood, and commonly occurs along with allergies like hay fever and asthma, according to the American Academy of Allergy, Asthma and Immunology.

There are numerous treatments for eczema, both topical and oral, but not all can be given to young kids.

"So, there's a big need for safe and effective treatments for young children," said study author Dr. Ian Myles. He is a researcher and staff clinician with the U.S. National Institute of Allergy and Infectious Diseases.

For the study, his team tested a topical probiotic against eczema in 20 children as young as 3 years of age. Over four months, 17 of the 20 saw their rashes and itchiness fade by more than 50%.

The children were also able to cut down on topical corticosteroids, a standard treatment for eczema -- but one that can cause side effects like thinning of the skin and stretch marks.

The probiotic therapy is a spray solution containing live Roseomonas mucosa bacteria. Those microbes are normally present on the skin, and past research has found that R. mucosa from people with healthy skin can treat eczema in lab mice.

In contrast, samples of the bacteria from people with eczema either had no effect, or made the skin condition worse.

It all fits with evidence that eczema involves an imbalance in the skin's microbiome. That refers to the vast array of bacteria and other microbes that naturally dwell on the skin and help maintain its health.

The skin, Myles explained, has to repair itself from daily wear-and-tear, and the microbiome assists in that. He said R. mucosa appears to produce oils that aid the skin's repair capacity.

The treatment also reduced staph bacteria on the children's skin, and those microbes can worsen eczema symptoms.

Dr. John Browning, a pediatric dermatologist, said, "I think this is a really interesting study." Browning was not involved in the research.

He said people with eczema often get staph infections and need antibiotic treatment. It's possible R. mucosa could be an alternative, according to Browning, who is based at Children's Hospital of San Antonio and Texas Dermatology and Laser Specialists.

The findings, published online Sept. 9 in the journal Science Translational Medicine, are based on 20 children and teenagers who were given the probiotic therapy for four months. They (or their parents) applied the spray solution twice a week for three months, and then every other day for the final month.

On average, Myles said, the kids' itchiness and rash improved by 60% to 75%, with no significant side effects.

And there were signs it could have lasting benefits. Eight months after the therapy was stopped, the good bacteria were still colonizing the children's skin -- indicating R. mucosa had "moved in," Myles explained.

That, he said, suggests the therapy could be one time only. It would still be possible, though, that whatever caused the bacterial imbalance in the skin could do it again.

Myles said a broader goal is to figure out what those factors are -- with diet, soaps and antibiotics being among the suspects.

Browning is part of another trial testing R. mucosa for treating eczema. But he does not think it is the only bacterium that matters.

"There could be a lot of variability patient to patient in whether this approach would be helpful," Browning said.

Myles agreed, noting that not all study patients responded to the probiotic.

It's unclear when the R. mucosa therapy could become commercially available. The U.S. National Institutes of Health has licensed it to a private company, Forte Biosciences, to further develop.

Myles said the company worked to freeze-dry the probiotic so it can be reconstituted with water, then sprayed on. That will make it shelf-stable.

"We anticipate this being something you can pick up at the pharmacy," he said.

More information

The American Academy of Allergy, Asthma and Immunology has more on eczema.




328 W. Claiborne St.
P.O. Box 964
Monroeville,
Alabama 36460
Tel: (251)575-4203
Fax:(251)575-9459


powered by centersite dot net